LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872104. A total of 3 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $25,586,000 | +33.4% | 2,382,286 | 0.0% | 1.69% | +68.4% |
| Q2 2015 | $19,177,000 | +22.3% | 2,382,286 | -85.7% | 1.00% | +41.2% |
| Q1 2015 | $15,675,000 | +3.3% | 16,676,000 | 0.0% | 0.71% | -3.7% |
| Q4 2014 | $15,175,000 | -7.8% | 16,676,000 | +42.8% | 0.74% | -12.1% |
| Q3 2014 | $16,463,000 | -12.4% | 11,676,000 | 0.0% | 0.84% | -5.1% |
| Q2 2014 | $18,798,000 | -6.9% | 11,676,000 | 0.0% | 0.88% | -11.1% |
| Q1 2014 | $20,199,000 | -3.9% | 11,676,000 | 0.0% | 0.99% | -2.3% |
| Q4 2013 | $21,017,000 | -24.4% | 11,676,000 | 0.0% | 1.02% | -7.8% |
| Q3 2013 | $27,789,000 | +9.7% | 11,676,000 | 0.0% | 1.10% | -2.7% |
| Q2 2013 | $25,337,000 | – | 11,676,000 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 29,782,609 | $64,628,000 | 99.85% |
| Artal Group S.A. | 253,372,135 | $549,818,000 | 17.30% |
| NEA Management Company, LLC | 11,676,000 | $25,337,000 | 1.13% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 250,000 | $543,000 | 0.39% |
| WILLIAM HARRIS INVESTORS INC | 204,342 | $443,000 | 0.14% |
| HOWARD HUGHES MEDICAL INSTITUTE | 136,528 | $296,000 | 0.10% |
| Southeast Asset Advisors Inc. | 66,555 | $144,000 | 0.07% |
| SMITH ASSET MANAGEMENT GROUP LP | 535,455 | $1,162,000 | 0.05% |
| Teton Advisors, Inc. | 230,000 | $499,000 | 0.04% |
| USCA RIA LLC | 40,000 | $87,000 | 0.04% |